Survival Improves With Open Hysterectomy for Cervical Cancer

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, June 28, 2024 -- For patients with early-stage cervical cancer, disease-free and overall survival are lower for patients undergoing minimally invasive versus open radical hysterectomy, according to a study published online June 25 in the Journal of Clinical Oncology.

Pedro T. Ramirez, M.D., from the Methodist Hospital in Houston, and colleagues compared overall survival between open and minimally invasive radical hysterectomy among cervical cancer patients followed for 4.5 years. A total of 631 patients were enrolled: 319 and 312 were assigned to minimally invasive and open surgery, respectively; 289 and 274 underwent minimally invasive and open surgery, respectively.

The researchers found that at 4.5 years, disease-free survival was 85.0 and 96.0 percent in the minimally invasive and open groups, respectively (difference, −11.1 percent). Compared with open surgery, minimally invasive surgery was associated with a lower rate of disease-free survival (hazard ratio, 3.91). At 4.5 years, the rates of overall survival were 90.6 and 96.2 percent for the minimally invasive and open surgery groups, respectively (hazard ratio for death from any cause, 2.71).

"On the basis of these findings, patients undergoing radical hysterectomy for early cervical cancer should undergo open surgery as recommended by guidelines, and minimally invasive radical hysterectomy should only be performed in clinical trials," the authors write.

Several authors disclosed ties to the biopharmaceutical and medical device industries.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords